Long circulating PEGylated-chitosan nanoparticles of rosuvastatin calcium: Development and in vitro and in vivo evaluations.
Published Feb 1, 2018 · Mukundkumar Rameshbhai Hirpara, Jyothsna Manikkath, K. Sivakumar
International journal of biological macromolecules
44
Citations
0
Influential Citations
Abstract
Abstract removed due to Elsevier request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.
Study Snapshot
Key takeawayLong-circulating PEGylated chitosan nanoparticles of rosuvastatin calcium show prolonged drug release and better therapeutic action, potentially improving the pharmacokinetics and pharmacodynamics of statins.
PopulationOlder adults (50-71 years)
Sample size24
MethodsObservational
OutcomesBody Mass Index projections
ResultsSocial networks mitigate obesity in older groups.